PHIO PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Jun 2022)
What this means for you
This application is over — abandoned 27 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88170269
- Mark type
- Stylized text
- Filed
- 26 Oct 2018
- Published for opposition
- 26 Mar 2019
- Abandoned
- 27 Jun 2022
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for use in the treatment of cancer
Owner
- PHIO PHARMACEUTICALS CORP., MARLBOROUGH, MA, US
- PHIO PHARMACEUTICALS CORP., MARLBOROUGH, MA, US
- RXi Pharmaceuticals Corporation, Marlborough, MA, US
Prosecution history
- 27 Jun 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Jun 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2021 — SOU EXTENSION 5 GRANTED
- 12 Nov 2021 — SOU EXTENSION 5 FILED
- 19 Nov 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 14 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2021 — SOU EXTENSION 4 GRANTED
- 12 May 2021 — SOU EXTENSION 4 FILED
- 12 May 2021 — SOU TEAS EXTENSION RECEIVED
- 13 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Nov 2020 — SOU EXTENSION 3 GRANTED
- 11 Nov 2020 — SOU EXTENSION 3 FILED
- 11 Nov 2020 — SOU TEAS EXTENSION RECEIVED